Literature DB >> 3224500

Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction.

N Muthukumaran1, S Ma, A H Reddi.   

Abstract

Subcutaneous implantation of demineralized collagenous bone matrix results in local induction of new bone formation. The dose dependence of bone induction was investigated using different amounts of rat demineralized bone matrix (DBM) and also osteogenin-enriched fraction with and without inactive collagenous bone matrix (ICBM). There is a threshold for bone induction; at least 10 mg of DBM is required. There is a dose dependent increase in bone induction between 10 to 25 mg. Exogenous type I collagen was found to be stimulatory to bone induction when suboptimal doses of DBM are employed. The activity of osteogenin-enriched dissociative extract was enhanced by addition of ICBM. These results imply that optimal bone induction requires the combined action of soluble osteogenin-enriched fraction and insoluble collagenous substratum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3224500     DOI: 10.1016/s0174-173x(88)80016-5

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  8 in total

1.  Radiation-sterilized insoluble collagenous bone matrix is a functional carrier of osteogenin for bone induction.

Authors:  R W Katz; G C Felthousen; A H Reddi
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

2.  Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin.

Authors:  S Vukicevic; F P Luyten; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins.

Authors:  Maurice Hinsenkamp; Jean-Francois Collard
Journal:  Int Orthop       Date:  2014-10-22       Impact factor: 3.075

4.  Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.

Authors:  Y Fong; D Edelstein; E A Wang; M Brownlee
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

5.  Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects.

Authors:  L J Marden; R S Fan; G F Pierce; A H Reddi; J O Hollinger
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Experimental model of heterotopic ossification in Wistar rats.

Authors:  T G G Zotz; J B de Paula; A D L Moser
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

Review 7.  Demineralized bone matrix in bone repair: history and use.

Authors:  Elliott Gruskin; Bruce A Doll; F William Futrell; John P Schmitz; Jeffrey O Hollinger
Journal:  Adv Drug Deliv Rev       Date:  2012-06-21       Impact factor: 15.470

Review 8.  Evaluation of bone morphogenic proteins in periodontal practice.

Authors:  Supreet Kaur; Vishakha Grover; Harkiran Kaur; Ranjan Malhotra
Journal:  Indian J Dent       Date:  2016 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.